Literature DB >> 21702654

Bacteria and asthma: more there than we thought.

Daniel E Dulek1, R Stokes Peebles.   

Abstract

In a recently performed case-control study, characteristics of the airway microbiota in suboptimally controlled adult asthmatics were compared with those of healthy, nonasthmatic adult subjects. Bacterial burden was significantly greater in asthmatic subjects. Further, increased airway microbiota variability and diversity were correlated with increased bronchial hyper-responsiveness. Although several limitations are present, this study provides an intriguing initial insight into the possible relationship between the airway microbiota and asthma pathogenesis.

Entities:  

Year:  2011        PMID: 21702654      PMCID: PMC3929126          DOI: 10.1586/ers.11.33

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  16 in total

1.  Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae.

Authors:  P N Black; F Blasi; C R Jenkins; R Scicchitano; G D Mills; A R Rubinfeld; R E Ruffin; P R Mullins; J Dangain; B C Cooper; D B David; L Allegra
Journal:  Am J Respir Crit Care Med       Date:  2001-08-15       Impact factor: 21.405

2.  A trial of clarithromycin for the treatment of suboptimally controlled asthma.

Authors:  E Rand Sutherland; Tonya S King; Nikolina Icitovic; Bill T Ameredes; Eugene Bleecker; Homer A Boushey; William J Calhoun; Mario Castro; Reuben M Cherniack; Vernon M Chinchilli; Timothy J Craig; Loren Denlinger; Emily A DiMango; John V Fahy; Elliot Israel; Nizar Jarjour; Monica Kraft; Stephen C Lazarus; Robert F Lemanske; Stephen P Peters; Joe Ramsdell; Christine A Sorkness; Stanley J Szefler; Michael J Walter; Stephen I Wasserman; Michael E Wechsler; Hong Wei Chu; Richard J Martin
Journal:  J Allergy Clin Immunol       Date:  2010-10       Impact factor: 10.793

3.  Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma.

Authors:  Yvonne J Huang; Craig E Nelson; Eoin L Brodie; Todd Z Desantis; Marshall S Baek; Jane Liu; Tanja Woyke; Martin Allgaier; Jim Bristow; Jeanine P Wiener-Kronish; E Rand Sutherland; Tonya S King; Nikolina Icitovic; Richard J Martin; William J Calhoun; Mario Castro; Loren C Denlinger; Emily Dimango; Monica Kraft; Stephen P Peters; Stephen I Wasserman; Michael E Wechsler; Homer A Boushey; Susan V Lynch
Journal:  J Allergy Clin Immunol       Date:  2010-12-30       Impact factor: 10.793

4.  The effect of telithromycin in acute exacerbations of asthma.

Authors:  Sebastian L Johnston; Francesco Blasi; Peter N Black; Richard J Martin; David J Farrell; Richard B Nieman
Journal:  N Engl J Med       Date:  2006-04-13       Impact factor: 91.245

5.  Azithromycin or montelukast as inhaled corticosteroid-sparing agents in moderate-to-severe childhood asthma study.

Authors:  Robert C Strunk; Leonard B Bacharier; Brenda R Phillips; Stanley J Szefler; Robert S Zeiger; Vernon M Chinchilli; Fernando D Martinez; Robert F Lemanske; Lynn M Taussig; David T Mauger; Wayne J Morgan; Christine A Sorkness; Ian M Paul; Theresa Guilbert; Marzena Krawiec; Ronina Covar; Gary Larsen
Journal:  J Allergy Clin Immunol       Date:  2008-10-25       Impact factor: 10.793

6.  Routine antibiotics in hospital management of acute asthma.

Authors:  V A Graham; A F Milton; G K Knowles; R J Davies
Journal:  Lancet       Date:  1982-02-20       Impact factor: 79.321

7.  Community study of role of viral infections in exacerbations of asthma in 9-11 year old children.

Authors:  S L Johnston; P K Pattemore; G Sanderson; S Smith; F Lampe; L Josephs; P Symington; S O'Toole; S H Myint; D A Tyrrell
Journal:  BMJ       Date:  1995-05-13

8.  Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin.

Authors:  Monica Kraft; Gail H Cassell; Juno Pak; Richard J Martin
Journal:  Chest       Date:  2002-06       Impact factor: 9.410

9.  Innate immunity and intestinal microbiota in the development of Type 1 diabetes.

Authors:  Li Wen; Ruth E Ley; Pavel Yu Volchkov; Peter B Stranges; Lia Avanesyan; Austin C Stonebraker; Changyun Hu; F Susan Wong; Gregory L Szot; Jeffrey A Bluestone; Jeffrey I Gordon; Alexander V Chervonsky
Journal:  Nature       Date:  2008-09-21       Impact factor: 49.962

10.  Disordered microbial communities in asthmatic airways.

Authors:  Markus Hilty; Conor Burke; Helder Pedro; Paul Cardenas; Andy Bush; Cara Bossley; Jane Davies; Aaron Ervine; Len Poulter; Lior Pachter; Miriam F Moffatt; William O C Cookson
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240

View more
  4 in total

Review 1.  Chronic Inflammatory Diseases, Anti-Inflammatory Agents and Their Delivery Nanosystems.

Authors:  Daniela Placha; Josef Jampilek
Journal:  Pharmaceutics       Date:  2021-01-06       Impact factor: 6.321

Review 2.  Re-defining the unique roles for eosinophils in allergic respiratory inflammation.

Authors:  E A Jacobsen; N A Lee; J J Lee
Journal:  Clin Exp Allergy       Date:  2014-09       Impact factor: 5.018

Review 3.  The changing face of asthma and its relation with microbes.

Authors:  Chris S Earl; Shi-qi An; Robert P Ryan
Journal:  Trends Microbiol       Date:  2015-03-31       Impact factor: 17.079

Review 4.  Extracellular Vesicles, a Key Mediator to Link Environmental Microbiota to Airway Immunity.

Authors:  Youngwoo Choi; Hanki Park; Hae Sim Park; Yoon Keun Kim
Journal:  Allergy Asthma Immunol Res       Date:  2017-03       Impact factor: 5.764

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.